000 | 01777 a2200517 4500 | ||
---|---|---|---|
005 | 20250515141036.0 | ||
264 | 0 | _c20090305 | |
008 | 200903s 0 0 eng d | ||
022 | _a1778-7254 | ||
024 | 7 |
_a10.1016/j.jbspin.2008.05.004 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aOgata, Atsushi | |
245 | 0 | 0 |
_aEtanercept improved primary biliary cirrhosis associated with rheumatoid arthritis. _h[electronic resource] |
260 |
_bJoint bone spine _cJan 2009 |
||
300 |
_a105-7 p. _bdigital |
||
500 | _aPublication Type: Case Reports; Letter | ||
650 | 0 | 4 |
_aAnti-Inflammatory Agents, Non-Steroidal _xtherapeutic use |
650 | 0 | 4 |
_aAntirheumatic Agents _xtherapeutic use |
650 | 0 | 4 |
_aArthritis, Rheumatoid _xcomplications |
650 | 0 | 4 |
_aCysteine _xanalogs & derivatives |
650 | 0 | 4 | _aDrug Therapy, Combination |
650 | 0 | 4 | _aEtanercept |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunoglobulin G _xtherapeutic use |
650 | 0 | 4 |
_aLiver Cirrhosis, Biliary _xcomplications |
650 | 0 | 4 |
_aMethotrexate _xtherapeutic use |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aPrednisolone _xtherapeutic use |
650 | 0 | 4 |
_aReceptors, Tumor Necrosis Factor _xtherapeutic use |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 | _aWithholding Treatment |
700 | 1 | _aTerabe, Fumitaka | |
700 | 1 | _aNakanishi, Kaori | |
700 | 1 | _aKawai, Mari | |
700 | 1 | _aKuwahara, Yusuke | |
700 | 1 | _aHirano, Toru | |
700 | 1 | _aArimitsu, Jyunsuke | |
700 | 1 | _aHagihara, Keisuke | |
700 | 1 | _aShima, Yoshihito | |
700 | 1 | _aNarazaki, Masashi | |
700 | 1 | _aTanaka, Toshio | |
700 | 1 | _aKawase, Ichiro | |
773 | 0 |
_tJoint bone spine _gvol. 76 _gno. 1 _gp. 105-7 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.jbspin.2008.05.004 _zAvailable from publisher's website |
999 |
_c18313437 _d18313437 |